Contact us

Please note that we are not able to diagnose, advise, provide acute or chronic care, or make treatment referrals. If you need urgent help, please contact the emergency services or your doctor as soon as possible.

We receive many enquiries from people wishing to participate in our phase 3 programme of investigational COMP360 psilocybin treatment for treatment-resistant depression, and our phase 2 trials in post-traumatic stress disorder and anorexia nervosa.

To find out whether you may be eligible to take part in our phase 3 programme in treatment-resistant depression, please click here.

To find out more about our phase 2 trial in post-traumatic stress disorder, please click here.

To find out more about our phase 2 trial in anorexia nervosa, please click here.

For media enquiries, contact us at media@compasspathways.com.

If you are interested in being trained to support our clinical trials, please email us at TherapistTrainingEnquiries@compasspathways.com.

You can unsubscribe at any time. We include a link to unsubscribe at the bottom of all our emails. Read our Privacy Policy.